THE EFAMOL STORY
The only true international brand of fatty acid-based products, Efamol has led the way in developing scientifically-proven essential fatty acid health supplements for over 35 years.
Essential fatty acids (EFAs) were discovered, and the significant clinical research into their impact on human health began.
A group of researchers, including David Horrobin, published a scientific rationale indicating that Gamma-linolenic acid (GLA), derived from the seed of the evening primrose plant, could be beneficially linked to the quality of human health and nutrition.
Efamol Pure Evening Primrose Oil was one of the first brands supplying high quality supplements for hormonal balance and skin health to be launched.
The Efamol Research Institute is founded.
The launch of Efalex pioneered the development of the brain and eye health category.
Efamol was purchased by Royal Numico, a Dutch multi-national company with worldwide influence in the field of infant and clinical nutrition.
Efamol was acquired by the current management team, a group of individuals with extensive experience in the field of essential fatty acid nutrition, and so returned to independent ownership.
Efamol Biosciences Limited was acquired by a food supplement company, Wassen International Limited, to enable access to many more consumer markets across the globe.
Efalex Active Memory was launched. A new formula combining omega-3 fish oil with key nutrients known for their beneficial role in maintaining healthy brain function and performance.
Efalex re-launched as Efalex Omega-3 +6 in the UK.
Efamol is launched in South Africa.